Buscar
01/06/2026
Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001
Dossa, F, Callegaro, D, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Grignani, G, Brunello, A, Blay, JY, Beveridge, RD, Ferraresi, V, Lugowska, IA, Pizzamiglio, S, Verderio, P, Palassini, E, Bianchi, G, Stacchiotti, S, Bague, S, Coindre, JM, Dei Tos, AP, Gronchi, A. Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.11573. PMID:. IF:41.900(Q1/1D).
01/06/2026
Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
Costa-Comellas, L, Monforte, M, Sanchez-Montañez, A, Romero-Duque, P, Pegoraro, E, Díaz-Manera, J, Vlodavets, D, Maggi, L, Moscatelli, M, DAmico, A, Olivé, M, Alonso-Pérez, J, Comi, G, Escudero-Fernández, JM, Urcuyo, GS, Pichiecchio, A, Berardinelli, A, Claeys, KG, Bruno, C, Panicucci, C, Bortolani, S, Torchia, E, Ricci, E, Monges, S, Bevilacqua, JA, Diaz-Jara, J, Walter, MC, Thiele, S, Lokken, N, Vissing, J, Quijano-Roy, S, Carlier, RY, Voermans, NC, Marini-Bettolo, C, Guglieri, M, Straub, V, Leonardis, L, Munell, F, Gómez-Andrés, D, Tasca, G. Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies. Annals of Clinical and Translational Neurology. 2026; 13(6)DOI:10.1002/acn3.70303. PMID:41475892. IF:3.900(Q1/3D).
01/06/2026
Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson's disease
Stampacchia, S, Bernasconi, F, Van De Ville, D, Amico, E, Kohoutová, L, Taylor, JP, Thomas, A, Pagonabarraga, J, Kulisevsky, J, Blanke, O. Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson's disease. Nature Mental Health. 2026; 4(6)DOI:10.1038/s44220-026-00657-x. PMID:. IF:(Q/D).
01/06/2026
Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study)
Valls-Carbó, A, Millán, M, Castaño, C, De La Ossa, NP, Cardona, P, Flores, A, Biarnes, C, Boix, M, Urra, X, Terceño, M, Olivé-Gadea, M, Renom, PC, Rodríguez-Campello, A, Purroy, FF, Yugueros, B, Cánovas, D, Caamaño, IR, Beltrán-Mármol, B, Remollo, S, De Dios, M, Bashir, S, Aja, L, Gramegna, LL, Pastrana, M, Hernández-Pérez, M. Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study). European Stroke Journal. 2026; 11(6)DOI:10.1093/esj/aakag068. PMID:42308555. IF:4.500(Q1/2D).